CRBP icon

Corbus Pharmaceuticals

83 hedge funds and large institutions have $152M invested in Corbus Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less capital invested

Capital invested by funds: $166M → $152M (-$14M)

66% less call options, than puts

Call options by funds: $1.06M | Put options by funds: $3.15M

Holders
83
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.06M
Puts
$3.15M
Net Calls
Net Calls Change

Top Buyers

1 +$23.3M
2 +$3.13M
3 +$905K
4
IA
IFP Advisors
Florida
+$602K
5
Millennium Management
Millennium Management
New York
+$585K

Top Sellers

1 -$4.74M
2 -$2.27M
3 -$732K
4
Deutsche Bank
Deutsche Bank
Germany
-$524K
5
BlackRock
BlackRock
New York
-$469K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$545K
27
$535K
28
$528K
29
$528K
30
$454K
31
$447K
32
$378K
33
$348K
34
$339K
35
$329K
36
$321K
37
$299K
38
$285K
39
$278K
40
$269K
41
$268K
42
$218K
43
$213K
44
$201K
45
$192K
46
$192K
47
$158K
48
$144K
49
$135K
50
$128K